article
For now at least, Minnesota Vikings tailback Michael Bennett will eschew a second surgery on his injured left foot, ESPN.com has learned, and instead will undergo a less invasive procedure that he hopes might get him back on the field by midseason.
Likely within the next week, Bennett will have bone marrow extracted from his hip. The marrow will then be mixed with a protein agent known as Ignite, and injected in his foot, in a unique procedure developed by Charlotte, N.C.-based orthopedic surgeon Dr. Robert Anderson, the foot specialist who examined Bennett earlier this week.
The
purpose of the procedure is to stimulate and promote healing to the fractured fifth metatarsal bone, an area of the foot where blood flow is diminished. The foot will then be re-cast and Bennett will resume electrical bone stimulation. The third-year veteran also will undergo hydrotherapy, with the workouts in a swimming pool aimed at reducing the pressure on his foot.
Following approximately one month of that program, the foot will be re-examined and probably scanned, and a determination on further treatment will be based on the results of that re-check. Even if progress remains slow at that point, surgery will not necessarily be indicated, said sources close to the Vikings star runner.
In fact,
there is some chance Bennett may continue the more benign treatments all the way through the season, in an effort to play at least part of the campaign. If that becomes the case, surgery might be delayed until January or beyond.
"One of the components," said a source, "is just how much pain Michael can tolerate.
The surgery is probably going to be necessary at some point. If it gets to a point where he can play and the pain isn't debilitating, then he'll play, because he likely wouldn't do any more damage to the foot."